María Benlloch García-rekin lankidetzan egindako argitalpenak (7)

2024

  1. Paraoxonase I Activity and Its Relationship with Nutrition in Amyotrophic Lateral Sclerosis

    Antioxidants, Vol. 13, Núm. 8

2023

  1. Lipid Profile in Multiple Sclerosis: Functional Capacity and Therapeutic Potential of Its Regulation after Intervention with Epigallocatechin Gallate and Coconut Oil

    Foods, Vol. 12, Núm. 20

2021

  1. Possible role of butyrylcholinesterase in fat loss and decreases in inflammatory levels in patients with multiple sclerosis after treatment with epigallocatechin gallate and coconut oil: A pilot study

    Nutrients, Vol. 13, Núm. 9

  2. Role of haptoglobin as a marker of muscular improvement in patients with multiple sclerosis after administration of epigallocatechin gallate and increase of beta-hydroxybutyrate in the blood: A pilot study

    Biomolecules, Vol. 11, Núm. 5

2020

  1. Possible reduction of cardiac risk after supplementation with epigallocatechin gallate and increase of ketone bodies in the blood in patients with multiple sclerosis. A pilot study

    Nutrients, Vol. 12, Núm. 12, pp. 1-14

2019

  1. Reply to “when is a ketogenic diet ketogenic? Comment on satiating effect of a ketogenic diet and its impact on muscle improvement and oxidation state in multiple sclerosis patients. Nutrients 2019, 11, 1156”

    Nutrients

  2. Satiating effect of a ketogenic diet and its impact on muscle improvement and oxidation state in multiple sclerosis patients

    Nutrients, Vol. 11, Núm. 5